BIOCRYST SCHEDULED TO PRESENT AT THE RODMAN & RENSHAW TECHVEST HEALTHCARE CONFERENCE
Birmingham, Alabama - October 21, 2004 - BioCryst Pharmaceuticals, Inc. (Nasdaq NM: BCRX) announced that Charles E. Bugg, Ph.D., Chairman and CEO, will be presenting at the Rodman & Renshaw Techvest Healthcare Conference on Tuesday, October 26, 2004, at 1:15 p.m. Eastern Time. Interested investors can listen to the presentation live over the Internet during the conference at the following address:
-
What: BioCryst Pharmaceuticals, Inc. Presentation at the Rodman & Renshaw Techvest Healthcare Conference
When: Tuesday, October 26, 2004, at 1:15 p.m. ET
Where: http://www.wallstreetwebcasting.com/webcast/rrshq4/bcrx/
How: Live over the Internet -- Simply log on to the web at the address above
For those unable to listen at the designated time, the webcast will remain available for replay on http://www.wallstreetwebcasting.com/webcast/rrshq4/bcrx/ for 90 days following the conference.
Founded in 1986, BioCryst Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development of small-molecule pharmaceuticals to treat cancer, cardiovascular and autoimmune diseases, and viral infections.
Contacts:
BioCryst Pharmaceuticals, Inc.
Mike Darwin
Chief Financial Officer
(205) 444-4600
Euro RSCG Life NRP
Sharon Weinstein (Investors)
(212) 845-4271
Wendy Lau (Media)
(212) 845-4272